How much do you agree with the following statements? *

	Strongly disagree	Disagree	Slightly disagree	Neither	Slightly agree	Agree	Strongly agree
The activity presented balanced, evidence-based content free of commercial bias.	The activity presented balanced, evidence-based content free of commercial bias. - Strongly disagree	The activity presented balanced, evidence-based content free of commercial bias. - Disagree	The activity presented balanced, evidence-based content free of commercial bias. - Slightly disagree	The activity presented balanced, evidence-based content free of commercial bias. - Neither	The activity presented balanced, evidence-based content free of commercial bias. - Slightly agree	The activity presented balanced, evidence-based content free of commercial bias. - Agree	The activity presented balanced, evidence-based content free of commercial bias. - Strongly agree
The presenter(s) used an effective teaching strategy.	The presenter(s) used an effective teaching strategy. - Strongly disagree	The presenter(s) used an effective teaching strategy. - Disagree	The presenter(s) used an effective teaching strategy. - Slightly disagree	The presenter(s) used an effective teaching strategy. - Neither	The presenter(s) used an effective teaching strategy. - Slightly agree	The presenter(s) used an effective teaching strategy. - Agree	The presenter(s) used an effective teaching strategy. - Strongly agree
The presentation slides / digital materials / resources and handouts were high quality.	The presentation slides / digital materials / resources and handouts were high quality. - Strongly disagree	The presentation slides / digital materials / resources and handouts were high quality. - Disagree	The presentation slides / digital materials / resources and handouts were high quality. - Slightly disagree	The presentation slides / digital materials / resources and handouts were high quality. - Neither	The presentation slides / digital materials / resources and handouts were high quality. - Slightly agree	The presentation slides / digital materials / resources and handouts were high quality. - Agree	The presentation slides / digital materials / resources and handouts were high quality. - Strongly agree
The content was relevant to / useful for my professional practice.	The content was relevant to / useful for my professional practice. - Strongly disagree	The content was relevant to / useful for my professional practice. - Disagree	The content was relevant to / useful for my professional practice. - Slightly disagree	The content was relevant to / useful for my professional practice. - Neither	The content was relevant to / useful for my professional practice. - Slightly agree	The content was relevant to / useful for my professional practice. - Agree	The content was relevant to / useful for my professional practice. - Strongly agree
The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care.	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Strongly disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Slightly disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Neither	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Slightly agree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Agree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Strongly agree
The overall quality of the educational activity was excellent.	The overall quality of the educational activity was excellent. - Strongly disagree	The overall quality of the educational activity was excellent. - Disagree	The overall quality of the educational activity was excellent. - Slightly disagree	The overall quality of the educational activity was excellent. - Neither	The overall quality of the educational activity was excellent. - Slightly agree	The overall quality of the educational activity was excellent. - Agree	The overall quality of the educational activity was excellent. - Strongly agree

The activity successfully achieved its learning objectives by enhancing my ability to: *

	Strongly disagree	Disagree	Slightly disagree	Neither	Slightly agree	Agree	Strongly agree
1. Interpret and apply the 2018 American Heart Association/American College of Cardiology (ACC)/Multi-society guidelines for cholesterol management in adults.	1. Interpret and apply the 2018 American Heart Association/American College of Cardiology (ACC)/Multi-society guidelines for cholesterol management in adults. - Strongly disagree	1. Interpret and apply the 2018 American Heart Association/American College of Cardiology (ACC)/Multi-society guidelines for cholesterol management in adults. - Disagree	1. Interpret and apply the 2018 American Heart Association/American College of Cardiology (ACC)/Multi-society guidelines for cholesterol management in adults. - Slightly disagree	1. Interpret and apply the 2018 American Heart Association/American College of Cardiology (ACC)/Multi-society guidelines for cholesterol management in adults. - Neither	1. Interpret and apply the 2018 American Heart Association/American College of Cardiology (ACC)/Multi-society guidelines for cholesterol management in adults. - Slightly agree	1. Interpret and apply the 2018 American Heart Association/American College of Cardiology (ACC)/Multi-society guidelines for cholesterol management in adults. - Agree	1. Interpret and apply the 2018 American Heart Association/American College of Cardiology (ACC)/Multi-society guidelines for cholesterol management in adults. - Strongly agree
2. Implement updated LDL-C and non-HDL-C goals from the 2022 ACC Expert Consensus Statement and confidently select appropriate add-on therapies for patients not at target.	2. Implement updated LDL-C and non-HDL-C goals from the 2022 ACC Expert Consensus Statement and confidently select appropriate add-on therapies for patients not at target. - Strongly disagree	2. Implement updated LDL-C and non-HDL-C goals from the 2022 ACC Expert Consensus Statement and confidently select appropriate add-on therapies for patients not at target. - Disagree	2. Implement updated LDL-C and non-HDL-C goals from the 2022 ACC Expert Consensus Statement and confidently select appropriate add-on therapies for patients not at target. - Slightly disagree	2. Implement updated LDL-C and non-HDL-C goals from the 2022 ACC Expert Consensus Statement and confidently select appropriate add-on therapies for patients not at target. - Neither	2. Implement updated LDL-C and non-HDL-C goals from the 2022 ACC Expert Consensus Statement and confidently select appropriate add-on therapies for patients not at target. - Slightly agree	2. Implement updated LDL-C and non-HDL-C goals from the 2022 ACC Expert Consensus Statement and confidently select appropriate add-on therapies for patients not at target. - Agree	2. Implement updated LDL-C and non-HDL-C goals from the 2022 ACC Expert Consensus Statement and confidently select appropriate add-on therapies for patients not at target. - Strongly agree
3. Recognize and appropriately utilize alternative lipid monitoring parameters in select patient groups, considering their cost-effectiveness and impact on healthcare expenditures.	3. Recognize and appropriately utilize alternative lipid monitoring parameters in select patient groups, considering their cost-effectiveness and impact on healthcare expenditures. - Strongly disagree	3. Recognize and appropriately utilize alternative lipid monitoring parameters in select patient groups, considering their cost-effectiveness and impact on healthcare expenditures. - Disagree	3. Recognize and appropriately utilize alternative lipid monitoring parameters in select patient groups, considering their cost-effectiveness and impact on healthcare expenditures. - Slightly disagree	3. Recognize and appropriately utilize alternative lipid monitoring parameters in select patient groups, considering their cost-effectiveness and impact on healthcare expenditures. - Neither	3. Recognize and appropriately utilize alternative lipid monitoring parameters in select patient groups, considering their cost-effectiveness and impact on healthcare expenditures. - Slightly agree	3. Recognize and appropriately utilize alternative lipid monitoring parameters in select patient groups, considering their cost-effectiveness and impact on healthcare expenditures. - Agree	3. Recognize and appropriately utilize alternative lipid monitoring parameters in select patient groups, considering their cost-effectiveness and impact on healthcare expenditures. - Strongly agree
4. Effectively evaluate and manage statin intolerance in patients.	4. Effectively evaluate and manage statin intolerance in patients. - Strongly disagree	4. Effectively evaluate and manage statin intolerance in patients. - Disagree	4. Effectively evaluate and manage statin intolerance in patients. - Slightly disagree	4. Effectively evaluate and manage statin intolerance in patients. - Neither	4. Effectively evaluate and manage statin intolerance in patients. - Slightly agree	4. Effectively evaluate and manage statin intolerance in patients. - Agree	4. Effectively evaluate and manage statin intolerance in patients. - Strongly agree
5. Identify and describe emerging lipid-lowering therapeutics, with a focus on agents targeting Lipoprotein(a).	5. Identify and describe emerging lipid-lowering therapeutics, with a focus on agents targeting Lipoprotein(a). - Strongly disagree	5. Identify and describe emerging lipid-lowering therapeutics, with a focus on agents targeting Lipoprotein(a). - Disagree	5. Identify and describe emerging lipid-lowering therapeutics, with a focus on agents targeting Lipoprotein(a). - Slightly disagree	5. Identify and describe emerging lipid-lowering therapeutics, with a focus on agents targeting Lipoprotein(a). - Neither	5. Identify and describe emerging lipid-lowering therapeutics, with a focus on agents targeting Lipoprotein(a). - Slightly agree	5. Identify and describe emerging lipid-lowering therapeutics, with a focus on agents targeting Lipoprotein(a). - Agree	5. Identify and describe emerging lipid-lowering therapeutics, with a focus on agents targeting Lipoprotein(a). - Strongly agree

What do you anticipate changing or how will you apply what you learned in your professional practice? *

How will you apply what you learned when working with providers of other disciplines or members of your interprofessional healthcare team? *

What barriers, if any, do you see to implementing these changes? *

Please provide feedback on your experience navigating this website and completing the CE process. *

Based on your educational needs, what topics would you like to see addressed in future educational activities? *

Please discuss any additional concerns or comments about this program and indicate whether the program met your expectations. *

attestation checkbox *

I completed this educational activity independently and in its entirety.

Leave this field blank